Certara CoAuthor: The GenAI Writing Copilot That Cuts Regulatory Submission Timelines by 30%
Overview: How Certara CoAuthor’s AI‑Driven Regulatory Automation Platform Transforms Global Submission Writing Certara CoAuthor is an AI‑assisted regulatory automation platform that streamlines document review and authoring for complex healthcare and life sciences submissions within the regulatory automation and AI‑assisted document review and authoring category. It is designed to support the end‑to‑end lifecycle of regulatory documents, […]
Feature Categories
Overview: How Certara CoAuthor’s AI‑Driven Regulatory Automation Platform Transforms Global Submission Writing
Certara CoAuthor is an AI‑assisted regulatory automation platform that streamlines document review and authoring for complex healthcare and life sciences submissions within the regulatory automation and AI‑assisted document review and authoring category. It is designed to support the end‑to‑end lifecycle of regulatory documents, from initial drafting through iterative revisions, consistency checks, and finalisation for submission.
The platform addresses a persistent bottleneck in the industry: producing and maintaining large volumes of highly structured, interdependent content such as clinical study reports, risk‑benefit narratives, and regulatory dossiers under tight timelines. Traditional processes depend on manual drafting, version reconciliation, and line‑by‑line review across multiple stakeholders, which can introduce delays, inconsistencies, and substantial administrative overhead. Certara CoAuthor applies domain‑tuned natural language processing and generative AI models to generate first drafts from source materials, propose context‑aware revisions, and flag potential discrepancies or gaps, reducing the reliance on repetitive manual text creation and review.
By embedding AI directly into document workflows, Certara CoAuthor can shorten authoring cycles and lower the administrative burden on subject‑matter experts. Teams can reallocate time from formatting, cross‑checking, and text assembly toward higher‑value analytical and strategic tasks, while maintaining a coherent narrative and structure across related documents. In practice, this can speed up documentation through internal review and governance, and help organisations use their medical writing and regulatory operations capacity more efficiently.
What is Certara CoAuthor?
Certara CoAuthor is a generative AI–enabled regulatory and medical writing platform used to draft and refine documents such as clinical study reports, patient narratives, and regulatory submissions within regulatory automation and AI‑assisted document review and authoring. It is primarily used by pharmaceutical and biotech companies, medical writers, and regulatory affairs teams seeking to streamline the production of complex submission documents. CoAuthor combines a life science–specialised, client‑specific GPT with structured content authoring, eCTD templates, and Microsoft Word integration, which differentiates it from general‑purpose text AI tools and supports consistent, reproducible content creation with human‑in‑the‑loop oversight.
Why Do Leading Healthcare Teams Trust Certara CoAuthor?
-
Certara has joined the Veeva AI Partner Program to integrate CoAuthor with Veeva’s regulatory information management platform, aligning its generative AI writing capabilities with a widely used life sciences regulatory stack.
-
Certara collaborates with the U.S. FDA on biosimulation‑related grants and projects, indicating an ongoing technical relationship with a major regulator and experience operating in regulated drug development contexts.
-
Certara has established partnerships with organizations such as Quinten Health to combine pharmacometrics, health economics, and AI technologies for data‑driven drug development and market access, reinforcing its position in the biopharma ecosystem.
-
CoAuthor is delivered by Certara, a publicly listed company on Nasdaq (ticker CERT), which provides financial transparency and oversight relevant to long‑term vendor stability.
-
CoAuthor is described as a life science‑specialized generative AI platform that uses organization‑specific deployments to avoid data leakage, which is relevant for privacy and confidentiality concerns in healthcare and MedTech settings.
-
The platform is integrated with structured content authoring and eCTD‑aligned templates for regulatory and medical writing, indicating a design oriented toward consistent, submission‑ready documentation.
-
Certara reports having published tens of millions of pages in eCTD submissions via its broader regulatory solutions, suggesting substantial experience with global regulatory formats and expectations.
-
The company pursues an explicit AI‑enhancement and R&D investment strategy presented at major healthcare investor conferences, which may be relevant for assessing its long‑term product roadmap and support for AI‑driven tools like CoAuthor.
Share This AI Tool
Get a neutral, no obligation view of whether this AI tool fits your portfolio
